References
- Swales J. D., Thurston H., Queriroz F. P., Medins A., Holland J. Dual mechanism for experimental hypertension. Lancet 1971; 2: 1181
- Davis J. O. The pathogenesis of chronic renovascular hypertension. Ciro Res 1977; 40: 439
- Brunner H. R., Kirshman J. O., Sealey J. E., Laragh J. H. Hypertension of renal origin: Evidence for two different mechanisms. Science 1971; 174: 1344
- Freeman R. H., Davis J. O., Watkins B. E., Stephens G. A., Deforrest J. M. Effects of continuous converting enzyme blockade on renovascular hypertension in the rat. Am J Physiol 1979; 236(1)F21
- Levinsky N. G. The renal kallikrein-kinin system. Circ Res 1979; 44: 441
- Dunn M. J., Hood V. L. Prostaglandins and the kidney. Am J Physiol 1977; 233: F169
- Colina-Chourio J., McGiff J. C., Miller M. P., Nasjletti A. Possible influence of intrarenal generation of kinins on prostaglandin release from the rabbit perfused kidney. Br J Pharmacol 1976; 58: 165
- Nasjletti A., Colina-Chourio J. Interaction of mineralocorticoids, renal prostaglandins and the renal kallikrein-kinin system. Fed Proc 1976; 35: 189
- Poulsen K., Jörgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab 1974; 39: 816
- Fawcett J. K., Scott J. E. A rapid and pricise method for the determination of urea. J Clin Pathol 1960; 13: 156
- Bonsnes R. W., Taussky H. H. On colorimetric determination of creatinine by Jaffe reaction. J Biol Chem 1945; 158: 581
- Moriwaki C., Inoue N., Hojima Y., Moriya H. A new assay method for the esterolytic activity of kallikreins with chrormotropic acid. Yakugaku Zasshi 1971; 91: 413
- Nustad K., Pierce J. V. Purification of rat urinary kallikreins and their specific antibody. Biochemistry 1974; 13: 2312
- Bengis R. G., Coleman T. G., Young D. B., McCaa R. E. Long-term blockade of angiotensin formation in various normotensive and hypertensive rat models using converting enzyme inhibitor(SQ 14,225). Circ Res 1978; 43: 145, Suppl.I
- Bengis R. G., Coleman T. G. Antihypertensive effect of prolonged blockade of angiotensin formation in benign and malignant, one- and two-kidney Goldblatt hypertensive rats. Clin Sci 1979; 57: 53
- Thurston H., Swales J. D. Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor. Circ Res. 1978; 42: 588
- Marks E. S., Bing R. F., Thurston H., Swales J. D. Vasodepressor property of the converting enzyme inhibitor captopril(SQ 14,225): The role of factors other than renin-angiotensin blockade in the rat. Clin Sci 1980; 58: 1
- Clappison B. H., Anderson W. P., Johnston C. I. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Kidney International 1981; 20: 615
- Carretero O. A., Miyazaki S., Scicli A. G. Role of kinins in the acute antihypertensive effect of converting enzyme inhibitor, Captopril. Hypertension 1981; 3: 18
- Murthy V. S., Waldron T. L., Goldberg M. E. The mechanism of bradykinin potentiation after inhibition of angiotensin-converting enzyme by SQ 14,225 in conscious rabbits. Circ Res 1978; 43: 140, Suppl.I
- Scicli A. G., Gandolfi R., Carreterc O. A. Site of formation of kinins in the dog nephron. Am J Physiol 1978; 234: F36
- Carretero O. A., Scicli A. G. The renal kallikrein-kinin system in human and in experimental hypertension. Klin Wochenschr 1978; 56: 113, Suppl.I
- McGiff J. C., Wong P. Y-K. Compartmentalization of prostaglandins and prostacyclin within the kidney: implication for renal function. Fed Proc 1979; 38: 89